Hays Michael D.
Known title: CEO & PresidentCIK: 0001053133
Associated companies
Transaction History
| NRC | ▲ Buy | Option Exercise | 9,145 | $139K | 1/5/2026 | View on chart |
| NRC | ▲ Buy | Option Exercise | 10,014 | $132K | 1/2/2025 | View on chart |
| NRC | ▲ Buy | Option Exercise | 2,904 | $55K | 1/2/2024 | View on chart |
| NRC | ▼ Sell | Tax Withholding | 1,909 | $76K | 1/2/2024 | View on chart |
| NRC | ▼ Sell | Gift | 45,040 | $0 | 3/27/2023 | View on chart |
| NRC | ▲ Buy | Option Exercise | 10,938 | $159K | 1/3/2023 | View on chart |
| NRC | ▼ Sell | Gift | 7,000 | $0 | 8/19/2022 | View on chart |
| NRC | ▼ Sell | Gift | 19,000 | $0 | 5/20/2022 | View on chart |
| NRC | ▲ Buy | Option Exercise | 14,949 | $161K | 12/22/2021 | View on chart |
| NRC | ▼ Sell | Tax Withholding | 7,596 | $304K | 12/22/2021 | View on chart |
| NRC | ▼ Sell | Gift | 10,500 | $0 | 7/12/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
NRC Health dividend and governance topics in focus
Recent coverage highlights NRC Health's dividend profile and broader discussions on hospital board governance. The stock is currently trading with a low RSI and near a key support level, reflecting cautious sentiment. These articles provide context on the company's financial policies and industry standards rather than reporting on a specific corporate event.
NRC Health dividend and governance topics in focus. Recent coverage highlights NRC Health's dividend profile and broader discussions on hospital board governance. The stock is currently trading with a low RSI and near a key support level, reflecting cautious sentiment. These articles provide context on the company's financial policies and industry standards rather than reporting on a specific corporate event.